Enanta Pharmaceuticals’ (ENTA) Market Outperform Rating Reiterated at JMP Securities
JMP Securities reaffirmed their market outperform rating on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a report released on Tuesday,Benzinga reports. JMP Securities currently has a $21.00 price target on the biotechnology company’s stock. ENTA has been the topic of several other reports. HC Wainwright reaffirmed a “buy” rating and set a $18.00 […]
JMP Securities reaffirmed their market outperform rating on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a report released on Tuesday,Benzinga reports. JMP Securities currently has a $21.00 price target on the biotechnology company’s stock. ENTA has been the topic of several other reports. HC Wainwright reaffirmed a “buy” rating and set a $18.00 […]
